Will Takeda's DTC campaign cause spike in Rozerem Rxs?

July 24, 2006

Pharmacists may wake up to a rise in prescriptions for insomnia medication Rozerem (ramelteon), as Takeda Pharmaceuticals North America gets set to launch its first DTC campaign for the medication. The campaign, which includes print, on-line, and broadcast ads, carries the theme "Your Dreams Miss You."

Will Takeda's DTC campaign cause spike in RozeremRxs?

Pharmacists may wake up to a rise in prescriptions for insomnia medication Rozerem (ramelteon), as Takeda Pharmaceuticals North America gets set to launch its first DTC campaign for the medication. The campaign, which includes print, on-line, and broadcast ads, carries the theme "Your Dreams Miss You." The effort focuses on the problem of insomnia and next-day effects and how Rozerem can help.

To see more Hot off the Press news articles, click here http://www.drugtopics.com/Hot+off+the+Press.